European Organisation for Research and Treatment of Cancer - EORTC: Prostatic Neoplasms trials

The registry lists 20 Prostatic Neoplasms studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 5Phase 3 12No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)RecruitingNCT06462963Not applicable
• Intermittent Androgen Deprivation Therapy in the Era of AR Pathway InhibitorsRecruitingNCT05974774Phase 3
• Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate CancerWithdrawnNCT03488810Phase 3
• ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate CancerActive, not recruitingNCT02972060Phase 2
• Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate CancerActive, not recruitingNCT02799706Phase 3
• Phase III Radium 223 mCRPC-PEACE IIIActive, not recruitingNCT02194842Phase 3
• Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate CancerCompletedNCT01819285Phase 3
• TAK-700 in Castration Resistant Prostate CancerWithdrawnNCT01658527Phase 2
• Post-operative or Early Salvage XRT and ADT for High Risk PCaTerminatedNCT00949962Phase 3
• Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate CancerCompletedNCT00849082Phase 3
• Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsCompletedNCT00433602
• Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the ProstateCompletedNCT00085228Phase 2
• Assessing Quality of Life of Patients With Prostate CancerCompletedNCT00041301
• Radical Prostatectomy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00027794Phase 2
• MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00027781Phase 2
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate CancerCompletedNCT00021450Phase 3
• Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate CancerTerminatedNCT00014586Phase 3
• Hormone Therapy in Treating Patients With Advanced Prostate CancerCompletedNCT00003026Phase 3
• Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate CancerCompletedNCT00002511Phase 3
• Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone MetastasesCompletedNCT00002503Phase 3